Skip to content

Evaluation of Postoperative Pain Control in Ear Surgery

Evaluation of Ultrasound-Guided Auricularis Magnus Nerve Block for Postoperative Pain Control in Ear Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06869967
Enrollment
56
Registered
2025-03-11
Start date
2025-10-20
Completion date
2027-02-15
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Post Operative Pain

Keywords

Regional Anesthesia, Ear Surgery, Auricularis Magnus Nerve Block

Brief summary

Middle ear surgery is the most popular procedure in ear, nose and throat surgery. Increased sympathetic stimulation after surgery can activate the sympathetic system, causing hypertension and increased heart rate. As a result of these clinical conditions, hemorrhage can occur, which can impair the quality of the surgical field, which is undesirable in middle ear surgery.Clinical studies should be conducted with auricularis magnus nerve block applied in the perioperative period in middle ear surgery and postoperative pain scores.

Detailed description

Middle ear surgery is the most popular procedure in ear, nose and throat surgery. Increased sympathetic stimulation after surgery can activate the sympathetic system, causing hypertension and increased heart rate. As a result of these clinical conditions, hemorrhage can occur, which can impair the quality of the surgical field, which is undesirable in middle ear surgery.Ultrasound-guided auricularis magnus nerve block can be used as a potential solution to these problems. Ultrasound-guided peripheral nerve block can be visualized. It is appropriate and applicable to block a single distal nerve with a small dose of local anesthetic under ultrasound guidance. Ultrasound-guided blocking of the blocked area has reduced side effects with increased accuracy and accurate analgesic effect. In middle ear microsurgery, the nerve innervation of the postauricular incision area may not primarily originate from the auricularis magnus. Therefore, clinical studies should be conducted with auricularis magnus nerve block applied in the perioperative period in middle ear surgery and postoperative pain scores.

Interventions

PROCEDUREAuricularis Magnus Nerve Block

Auricularis Magnus Nerve block will be performed using 5 mL of %0.5 bupivacaine

PROCEDUREControl Group

Intravenous analgesics 1 gram paracetamol, 20 mg tenoxicam, 8 mg ondansetron will be administered.

Sponsors

Kocaeli University
Lead SponsorOTHER
Başakşehir Çam & Sakura City Hospital
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing CWD and Mastodectom * Patients undergoing elective surgery * ASA (American Society of Anesthesiologists) physical status classification I-II * Patients over 18 years of age

Exclusion criteria

* Anticoagulant use * Allergy to the drugs to be used * ASA (American Society of Anesthesiologists) physical status classification IV-V * Presence of infection in the area where the block will be applied * Patient's refusal to accept the block application or inability to cooperate with the patient

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumptionDuring the operationIntraoperative opioid consumption

Secondary

MeasureTime frameDescription
Morphine consumption1 hours after surgery(T1), 6 hours after surgery (T2), 12 hours after surgery (T3), 24 hours after surgery (T4)Postoperative morphine consumption
NRS Scores1 hours after surgery(T1), 6 hours after surgery (T2), 12 hours after surgery (T3), 24 hours after surgery (T4)NRS scores of the patients after the surgery (0=no pain, 10=worst pain imaginable)

Countries

Turkey (Türkiye)

Contacts

CONTACTNur Nazire YUCAL, MD
n_395@hotmail.com05443898086

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026